MALAT1 and non-small cell lung carcinoma: MALAT1 owes its name to its discovery as an overexpressed transcript in non-small cell lung cancer (NSCLC) metastases that provided an early-stage marker of NSCLC metastasis risk even before its molecular functions were characterized [72].